Mercer Global Advisors Inc Novo Cure LTD Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$56.6 - $89.9 $184,912 - $293,703	-3,267 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$60.15 - $84.52 $29,834 - $41,921	496 Added 17.9%	3,267 $271,000
Q4 2021 Feb 04, 2022	SELL	$75.08 - $121.99 $24,100 - $39,158	-321 Reduced 10.38%	2,771 $208,000
Q3 2021 Nov 10, 2021	BUY	$116.17 - $194.55 $27,764 - $46,497	239 Added 8.38%	3,092 $359,000
Q2 2021 Aug 10, 2021	BUY	$130.4 - $225.58 $90,888 - $157,229	697 Added 32.33%	2,853 $633,000
Q1 2021 May 11, 2021	BUY	$124.11 - $190.17 $267,581 - $410,006	2,156 New	2,156 $285,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.97B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.